These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 316334)

  • 1. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1979 Jun; 66(2):241-50. PubMed ID: 465877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure.
    Chiariello M; Ferro G; Santinelli V; Tari MG; Spinelli L; Condorelli M
    Jpn Heart J; 1980 Mar; 21(2):197-203. PubMed ID: 7373860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of mexiletine and disopyramide after cardioplegic arrest.
    Moritz A; Eckersberger F; Losert U; Probst P; Schreiner W; Wolner E
    Eur Surg Res; 1989; 21(6):327-35. PubMed ID: 2633930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.
    Walsh RA; Horwitz LD
    Circulation; 1979 Nov; 60(5):1053-8. PubMed ID: 487539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
    Thadani U; Manyari D; Gregor P; Olowoyeye J; Leach A; West RO; Parker JO
    Cathet Cardiovasc Diagn; 1981; 7(1):27-34. PubMed ID: 7214518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 17. Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine.
    Hoffmeister HM; Hepp A; Seipel L
    Eur Heart J; 1987 Oct; 8(10):1126-32. PubMed ID: 3119341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of disopyramide on postischemic and normal myocardium].
    Hoffmeister HM; Hörmann HP; Beyer M; Seipel L
    Klin Wochenschr; 1990 Dec; 68(23):1178-82. PubMed ID: 2280581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramide.
    Pfisterer M; Munoz A; Burkart F
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):247-51. PubMed ID: 2459557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.